On July 23, 2012, a jury awarded a Bakersfield, Calif., couple $5.5 million in a case against C.R. Bard Medical, the manufacturer of the Avaulta Mesh pelvic mesh implant. The plaintiffs alleged that C.R. Bard knew that the mesh was unsafe but decided to continue selling it.
"The hardest part, I will tell you, through this whole thing, is having to keep quiet, watching women still get hurt. But, I was legally not able to get out there …. So, when I got that verdict it was like 'Thank you God.' Now we can do something," said plaintiff Christine Scott in an article published by KGET.com
Following this plaintiffs' verdict, legal and medical professionals are now taking note. The Securities and Exchange Commission indicates that approximately 47,000 women have received pelvic mesh implants, and more than 600 pelvic mesh lawsuits have been filed against manufacturers.
Between 2005 and 2010, nearly 4,000 injuries were reported to the FDA in connection with a transvaginal/pelvic mesh device. Although Motley Rice did not represent Scott, Motley Rice attorneys do hold leadership roles in pelvic mesh cases filed in state and federal courts, representing hundreds of clients in lawsuits against numerous manufacturers that include Boston Scientific, American Medical Systems, Inc. (AMS), C.R. Bard, Inc., and Johnson & Johnson.
Read the full article on Bloomberg.
Motley Rice represents patients allegedly harmed by pelvic mesh and DePuy® hip implants. Learn more about how our medical lawyers fight for people hurt by pharmaceutical drugs and medical devices and work to hold accountable those responsible for negligent medical care, corporate wrongdoing, and inadequate warning, research and testing.
Please remember that every case is different. Any result we achieve for one client in one matter does not necessarily indicate similar results can be obtained for other clients.